Sanapsis Lite app analytics for December 23

Sanapsis Lite

Sanapsis Lite

  • Puheklinikka NET Oy
  • Apple App Store
  • Free
  • Medical
Sanapsis is an iPad application designed for professional Speech and Language Pathologists (SLPs). It's intended for use in therapy sessions with adult patients experiencing acquired language difficulties due to neurological impairments. Sanapsis Lite offers a preview of some exercises available in SanapsisPro. The full version, SanapsisPro, provides a wide array of speech therapy exercises and materials in three languages: English, Finnish, and Swedish. SanapsisPro turns your iPad into a comprehensive library of therapy ideas and materials. It's packed with exercises for all language faculties, each with varying levels of difficulty and accompanied by usage instructions and notes on what to observe during the task. Please note, Sanapsis is designed for use by an SLP in cooperation with the patient, not for independent use. If you're not a professional but seeking rehabilitation for language deficits independently, please contact a licensed SLP for advice. We look forward to your feedback and suggestions at sanapsis@puheklinikka.net.

Store Rank

The Store Rank is based on multiple parameters set by Google and Apple.

All Categories in
United States--
Medical in
United States--
Create an account to see avg.monthly downloadsContact us

Sanapsis Lite Ranking Stats Over Time

Similarweb's Usage Rank & Apple App Store Rank for Sanapsis Lite

Rank

No Data Available

Sanapsis Lite Ranking by Country

Counties in which Sanapsis Lite has the highest ranking in its main categories

No Data to Display

Top Competitors & Alternative Apps

Apps with a high probability of being used by the same users, from the same store.

Tinnitus: Resound Hearing Aid

Tinnitus: Resound Hearing Aid

DARIEM, TOO

e-INS 2023

e-INS 2023

International Neuromodulation Society

Reading Therapy

Reading Therapy

Tactus Therapy Solutions Ltd

miHipot CNV

miHipot CNV

Gobierno de Canarias

Sanapsis Lite VS.

December 23, 2024